Analysis on the implementation effect of policies on promoting the use of generic drugs in foreign countriesWANG Zhi-yuan, HE Yao-guang, FAN Ping-an, CHEN Jing, SHI Lu-wen2185-2192
Text mining and quantitative analysis of policies related to rare diseases and their drugsHAN Meng, GAO Zi-wen, LAN Ya-fei, ZHANG Meng, ZHANG Wan-jie, CHU Shu-zhen2193-2201
Study on policies of different countries on racial difference when accepting overseas clinical trial dataCHANG Ying-nan, GONG Jing-ran, CHEN Yu-wen2202-2206
Evaluation and analysis of the influence of patent term extension system on the development of new drugsXIAO Xi-xiang, CHEN Zhen-zhong2207-2212
Conception and discussion of establishing big data monitoring system of drugs based on infrared spectrumXIAO Yan, YUAN You-rong, XIN Ming, ZHENG Li-e2213-2217
A novel tyrosine kinase inhibitor sulfatinib for the treatment of neuroendocrine neoplasmsCUI Ying-jie, YANG Jie, LIU Mei, CHEN Fu-hao, HOU Ning2218-2222
Pharmacological effects and clinical evaluation of asciminib for chronic myeloid leukemiaLI Chun-xing, LIU Li-yan, CAI Jin-rui, LI Yan, LI Jia-yi, LIU Hua2223-2226
General chemistry manufacture and control issues during abbreviated new drug application of radiopharmaceuticalsHE Yan, SHI Yong-ping, BAI Yu2227-2230
An introduction to the Office of Compliance of the American drug regulatory agencyHE Hui, YANG Lan, WANG Miao, ZHAO Ming2231-2236
Overview of biological properties of antibiotic drugs using computational modeling and prediction technologyZHANG Dou-sheng, XU Ming-zhe2237-2241